Copy

Autoimmunity
Issue  29|   January 2017
ESL Biosciences, in partnership with Euroimmun AG, offer the most comprehensive range of diagnostic products and services for the determination of autoantibodies
EUROIMMUN Anti-dsDNA-NcX ELISA

A Non-Radioactive Alternative for the Serological Diagnosis of SLE

The use of anti-dsDNA RIA (the Farr assay) has its downside in the disposal of radioactive materials. Thus a non-radioactive alternative method that produces high specificity and sensitivity in detecting anti-dsDNA is much needed.

EUROIMMUN anti-dsDNA-NcX ELISA differs from conventional anti-dsDNA ELISA systems by using highly purified nucleosome as the linkage molecule between microplate surface and dsDNA molecules. Nucleosome molecules not only provide strong affinity to pure dsDNA, but antibodies against nucleosomes are also an exclusive marker for SLE. Using nucleosome as the linking molecule in Euroimmun anti-dsDNA-NcX ELISA reduces non-specific binding, and produces results that are high in sensitivity and specificity for SLE.
Euroimmun anti-dsDNA-NcX ELISA has been validated to be a safer and reliable alternative to the Farr assay. A study carried out at Liverpool Hospital in NSW Australia has shown that results produced by the anti-dsDNA-NcX ELISA system are in line with that of the Farr assay.

"Our preliminary data also suggests that the performance of the Anti-dsDNA-NcX ELISA is comparable to the Farr radioimmunoassay... Correlation with disease activity appears to be better by ELISA...".
- R Baker et al 2012, Phar lap and the filly: validating the anti-DSDNA-NCX IgG ELISA
 
For further information on local studies of anti-dsDNA-NcX ELISA, please contact your area sales representative. 
NZ
NZ
Australia
Australia
Website
Website
Twitter
Twitter
Facebook
Facebook
LinkedIn
LinkedIn
Google+
Google+
Copyright © 2016 ESL Biosciences (Australia) Pty Limited. All rights reserved.
unsubscribe from this list  |  update subscription preferences